Aims & Scope
Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes.
Current Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of drug targets. The journal also accepts for publication mini- & full-length review articles and drug clinical trial studies.
As the discovery, identification, characterization and validation of novel human drug targets for drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.
Ranking and Category
Bentham Press Release — NEWS
- New Issue Published Current Drug Targets Vol. 19 Issue 4
- New Issue Published Current Drug Targets Vol. 19 Issue 3
- New Issue Published Current Drug Targets Vol. 19 Issue 2
- New Issue Published Current Drug Targets Vol. 19 Issue 1
- New Issue Published Current Drug Targets Vol. 18 Issue 16
- New Issue Published Current Drug Targets Vol. 18 Issue 15
- New Issue Published Current Drug Targets Vol. 18 Issue 14
- Free Trial Request
- Most Accessed Article : Current Drug Targets in Obesity Pharmacotherapy – A Review
- New Issue Published Current Drug Targets Vol. 18 Issue 13
- Most Cited Article: Targeting the BRCA1/2 Tumor Suppressors
- Free Trial Request
- New Issue Published Current Drug Targets Vol. 18 Issue 12
- Most Accessed Article: Pazopanib in Renal Cell Carcinoma Dialysis Patients: A Mini-Review and a Case Report
- New Issue Published Current Drug Targets Vol. 18 Issue 11
- New Issue Published Current Drug Targets Vol. 18 Issue 10
- Open Access Article: TXNIP in Metabolic Regulation: Physiological Role and Therapeutic Outlook
- Call For Paper
- Most Accessed Article:Current Drug Targets in Obesity Pharmacotherapy – A Review
- Open Access Article: Pharmacological Chaperones that Protect Tetrahydrobiopterin Dependent Aromatic Amino Acid
- Call For Paper
- New Issue Published Current Drug Targets Vol. 18 Issue 9
- Free Trial Request
- Most Accessed Article Pazopanib in Renal Cell Carcinoma Dialysis Patients: A Mini-Review and a Case Report
- Open Access Article: Aspirin Intolerance: Experimental Models for Bed-to-Bench
- New Issue Published Current Drug Targets Vol. 18 Issue 8
- Issue Published Current Drug Targets Vol. 18 Issue 7
- Call For Paper
- Free Trial Request
- Open Access Article: Molecular Mechanisms and Treatment of Radiation-Induced Lung Fibrosis
- Issue Published Current Drug Targets Vol. 18 Issue 6
- Most Accessed Article: Predictive Diagnostic Pathology in the Target Therapy Era in Breast Cancer
- Call For Paper
- Free Trial Request
- Open Access Article: Aspirin Intolerance: Experimental Models for Bed-to-Bench
- New Issue Published Current Drug Targets Vol. 18 Issue 5
- Issue Published Current Drug Targets Vol. 18 Issue 4
- Most Accessed Article: Pazopanib in Renal Cell Carcinoma Dialysis Patients: A Mini-Review and a Case Report
- Free Online Current Drug Targets Vol. 18 Issue 1
- Issue Published Current Drug Targets Vol. 18 Issue 3
- Call For Paper
- Free Trial Request
- Most Accessed Article: The Antioxidant Effects of Radix Astragali (Astragalus membranaceus and Related Species) in Protecting Tissues from Injury and Disease
- Highlighted Article: New Pharmacological Approaches Using Polyphenols on the Physiopathology of Neuropathic Pain
- Most Cited Article: Targeting the BRCA1/2 Tumor Suppressors
- Issue Published Current Drug Targets Vol. 18 Issue 2
- Most Accessed Article: Antioxidants as a Potential Preventive and Therapeutic Strategy for Cadmium
- Call For Paper
- Free Trial Request
- Podcast for (Targeting MDM4 as a Novel Therapeutic Approach for Hematologic Malignancies)
- Free Online Issue of Current Drug Targets
- Issue Published Current Drug Targets Vol.18 Issue 1
- Highlighted Article: Astrocytes: Adhesion Molecules and Immunomodulation
- Free Trial Request
- Issue Current Drug Targets Vol 17 Issue 16
- Call For Paper
- Highlighted Article: The Challenges of Modeling Drug Resistance to Antiangiogenic Therapy
- Most Cited Article: Targeting the BRCA1/2 Tumor Suppressors
- Free Trial Offer
-
Highlighted Article Flyer for the journal “Current Drug Targets” Volume 17, Number 11
- In cancer and aging, interconnected roles for apoptosis and cellular senescence
- Phosphonate emerging zinc binding group in matrix metalloproteinase inhibitors
-
Highlighted Article Flyer for the journal “Current Drug Targets” Volume 17, Number 8
